Performance of a novel eight-color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia.
Xiao ChenXia ChenSishu ZhaoYu ShiNinghan ZhangZhen GuoChun QiaoHuimin JinLiying ZhuHuayuan ZhuJianyong LiYu-Jie WuPublished in: Cytometry. Part B, Clinical cytometry (2024)
Collectively, this study demonstrated that the CD45-ROR1 panel is a reliable method for MRD assessment of CLL with high sensitivity, reproducibility, and reliability.